{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:51:20Z","timestamp":1780599080681,"version":"3.54.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Gluten degrading enzymes, which are commonly referred to as \u201cglutenases,\u201d represent attractive candidates for the development of a pharmacological treatment of gluten related disorders, such as coeliac disease (CeD). Endoprotease-40 (E40), a novel glutenase secreted by the actinomycete <jats:italic>Actinoallomurus<\/jats:italic> A8 and recombinantly produced in <jats:italic>S. lividans<\/jats:italic> TK24, was shown to be active at pH 3 to 6 (optimum pH 5), resistant to pepsin and trypsin degradation, able to destroy immunotoxicity of both gliadin 33-mer peptide and whole proteins and to strongly reduce the response of specific T cells when added to gliadin in <jats:italic>in vitro<\/jats:italic> gastrointestinal digestion. This study aims to functionally assess the capabilities of Endoprotease-40 (E40) to detoxify residual gluten immunogenic peptides in gastrointestinal digesta of food matrices made of soft and durum wheat. The INFOGEST harmonized protocols were applied to the multicompartmental model of simulated human gastrointestinal digestion, for the quantitative assessment of residual gluten in liquid (beer) and solid (bread and pasta) foods, made of either soft or durum wheat. Proteomic and immunological techniques, and functional assays on intestinal T cell lines from celiac disease patients were used to identify gluten-derived immunogenic peptide sequences surviving in gastric and gastrointestinal digesta after the addition of E40 at increasing enzyme: wheat proteins ratios. During the gastric phase (2 h incubation time), the addition of E40 demonstrated an extensive (\u2265 95%) dose-dependent detoxification of whole gluten in real food matrices. Overall, the residual gluten content was found at, or even below, the 20 ppm gluten-free threshold for soft and durum wheat-based food. Furthermore, unlike in untreated gastrointestinal digesta, none of the immunodominant \u03b1-gliadin peptides survived in E40-treated digesta. Traces of \u03c9- and \u03b3-gliadin derived immunogenic peptides were still detected in E40-treated digesta, but unable to stimulate celiac-intestinal T cells. In conclusion, E40 is a promising candidate for the oral enzymatic therapy of CeD, as a stand-alone enzyme being efficient along the complete gastrointestinal digestion of gluten.<\/jats:p>","DOI":"10.3389\/fnut.2022.974771","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T10:16:38Z","timestamp":1662632198000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["E40 glutenase detoxification capabilities of residual gluten immunogenic peptides in in vitro gastrointestinal digesta of food matrices made of soft and durum wheat"],"prefix":"10.3389","volume":"9","author":[{"given":"Gianfranco","family":"Mamone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Comelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Di Stasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Mottola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Siano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Cavaletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gianfrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/apt.16534","article-title":"Presence of high-risk HLA genotype is the most important individual risk factor for coeliac disease among at-risk relatives.","volume":"54","author":"Paavola","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1380-z","article-title":"Celiac disease: a comprehensive current review.","volume":"17","author":"Caio","year":"2019","journal-title":"BMC Med."},{"key":"B3","doi-asserted-by":"crossref","first-page":"G996","DOI":"10.1152\/ajpgi.00136.2002","article-title":"Intestinal digestive resistance of immunodominant gliadin peptides.","volume":"28","author":"Hausch","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00251-012-0599-z","article-title":"Nomenclature and listing of celiac disease relevant gluten T cell epitopes restricted by HLA-DQ molecules.","volume":"64","author":"Sollid","year":"2012","journal-title":"Immunogenetics."},{"key":"B5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1084\/jem.191.4.603","article-title":"The intestinal T cell response to \u03b1-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.","volume":"191","author":"Arentz-Hansen","year":"2000","journal-title":"J Exp Med."},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001012","article-title":"Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.","volume":"2","author":"Tye-Din","year":"2010","journal-title":"Sci Transl Med."},{"key":"B7","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1053\/j.gastro.2009.09.008","article-title":"Celiac disease: from pathogenesis to novel therapies.","volume":"137","author":"Schuppan","year":"2009","journal-title":"Gastroenterology."},{"key":"B8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.imlet.2005.02.017","article-title":"Adaptive and innate immune responses in celiac disease.","volume":"99","author":"Gianfrani","year":"2005","journal-title":"Immunol Lett."},{"key":"B9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2249.2005.02783.x","article-title":"The immune recognition of gluten in coeliac disease.","volume":"140","author":"Ciccocioppo","year":"2005","journal-title":"Clin Exp Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European society for the study of coeliac disease (ESsCD) guideline for coeliac disease and other gluten-related disorder.","volume":"7","author":"Al-Toma","year":"2019","journal-title":"United European Gastroenterol J."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2036.2008.03669.x","article-title":"Systematic review: tolerable amount of gluten for people with coeliac disease.","volume":"27","author":"Akobeng","year":"2008","journal-title":"Aliment Pharmacol Ther."},{"key":"B12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/B978-0-12-416039-2.00013-6","article-title":"Oral enzyme therapy for celiac sprue.","volume":"502","author":"Bethune","year":"2012","journal-title":"Methods Enzymol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41575-020-00378-1","article-title":"Current and emerging therapies for coeliac disease.","volume":"18","author":"Kivel\u00e4","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28353-1","article-title":"An efficient urine peptidomics workflow identifies chemically defined dietary gluten peptides from patients with celiac disease.","volume":"13","author":"Palanski","year":"2022","journal-title":"Nat Commun."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48299-7","article-title":"E40, a novel microbial protease efficiently detoxifying gluten proteins, for the dietary management of gluten intolerance.","volume":"9","author":"Cavaletti","year":"2019","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1039\/C3FO60702J","article-title":"A standardised static in vitro digestion method suitable for food - an international consensus.","volume":"5","author":"Minekus","year":"2014","journal-title":"Food Funct."},{"key":"B17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41596-018-0119-1","article-title":"INFOGEST static in vitro simulation of gastrointestinal food digestion.","volume":"14","author":"Brodkorb","year":"2019","journal-title":"Nat Protoc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.foodres.2017.12.049","article-title":"Digestion of milk proteins: comparing static and dynamic in vitro digestion systems with in vivo data.","volume":"118","author":"Egger","year":"2019","journal-title":"Food Res Int."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201901032","article-title":"In celiac disease patients the in vivo challenge with the Diploid Triticum monococcum elicits a reduced immune response compared to hexaploid wheat.","volume":"64","author":"Picascia","year":"2020","journal-title":"Mol Nutr Food Res."},{"key":"B20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/10408347.2012.751787","article-title":"An overview of the kjeldahl method of nitrogen determination. part ii. sample preparation, working scale, instrumental finish, and quality control.","volume":"43","author":"Saez-Plaza","year":"2013","journal-title":"Crit Rev Anal Chem."},{"key":"B21","article-title":"Estimation of dietary gluten content using total protein in relation to gold standard testing in a variety of foods.","volume":"4","author":"Assor","year":"2014","journal-title":"J Nutr Food Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejpb.2016.09.009","article-title":"Resolving the physiological conditions in bioavailability and bioequivalence studies: comparison of fasted and fed state.","volume":"108","author":"Schneider","year":"2016","journal-title":"Eur J Pharm Biopharm."},{"key":"B23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jconrel.2015.10.022","article-title":"Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies.","volume":"220","author":"Koziolek","year":"2015","journal-title":"J Control Release."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1208\/s12248-016-9952-8","article-title":"A quantitative review and meta-models of the variability and factors affecting oral drug absorption\u2014part i: gastrointestinal pH.","volume":"18","author":"Abuhelwa","year":"2016","journal-title":"AAPS J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/00042737-200510000-00008","article-title":"Report of a collaborative trial to investigate the performance of the R5 enzyme linked immunoassay to determine gliadin in gluten-free food.","volume":"17","author":"M\u00e9ndez","year":"2005","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.talanta.2011.12.073","article-title":"Comprehensive analysis of gluten in processed foods using a new extraction method and a competitive ELISA based on the R5 antibody.","volume":"91","author":"Mena","year":"2012","journal-title":"Talanta."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.4049\/jimmunol.0803181","article-title":"Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.","volume":"182","author":"Camarca","year":"2009","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/pai.12720","article-title":"Gliadin-reactive T cells in Italian children from prevent CD cohort at high risk of celiac disease.","volume":"28","author":"Camarca","year":"2017","journal-title":"Pediatr Allergy Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/mnfr.201500126","article-title":"Extensive in vitro gastrointestinal digestion markedly reduces the immune-toxicity of Triticum monococcum wheat: implication for celiac disease.","volume":"59","author":"Gianfrani","year":"2015","journal-title":"Mol Nutr Food Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1021\/jf505461x","article-title":"Tracking the fate of pasta (T. Durum semolina) immunogenic proteins by in vitro simulated digestion.","volume":"63","author":"Mamone","year":"2015","journal-title":"J Agric Food Chem."},{"key":"B31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ddmod.2016.06.002","article-title":"Static and dynamic in vitro digestion models to study protein stability in the gastrointestinal tract.","volume":"17","author":"Dupont","year":"2015","journal-title":"Drug Discov Today Dis Models."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1021\/pr050173t","article-title":"Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.","volume":"4","author":"Shan","year":"2005","journal-title":"J. Proteome Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2021.03.019","article-title":"Gluten degradation, pharmacokinetics, safety, and tolerability of TAK-062, an engineered enzyme to treat celiac disease.","volume":"161","author":"Pultz","year":"2021","journal-title":"Gastroenterology."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112499","article-title":"Rationally engineered prolyl endopeptidases from Sphingomonas capsulata with improved hydrolytic activity towards pathogenic peptides of celiac diseases.","volume":"15","author":"Xiao","year":"2020","journal-title":"Eur J Med Chem."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.00011","article-title":"Directed-Mutagenesis of Flavobacterium meningosepticum prolyl-oligopeptidase and a glutamine-specific endopeptidase from barley.","volume":"7","author":"Osorio","year":"2020","journal-title":"Front Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1053\/j.gastro.2005.06.016","article-title":"Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.","volume":"129","author":"Matysiak-Budnik","year":"2005","journal-title":"Gastroenterology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejps.2018.02.032","article-title":"Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.","volume":"118","author":"Birch","year":"2018","journal-title":"Eur J Pharm Sci."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2020.109317","article-title":"Antiproliferative activity of green, black tea and olive leaves polyphenols subjected to biosorption and in vitro gastrointestinal digestion in Caco-2 cells.","volume":"136","author":"Jilani","year":"2020","journal-title":"Food Res Int."},{"key":"B39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.gastro.2007.04.008","article-title":"Enhancement of dietary protein digestion by conjugated bile acids.","volume":"133","author":"Gass","year":"2007","journal-title":"Gastroenterology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1124\/jpet.104.073312","article-title":"Prolyl Endopeptidase-mediated destruction of T Cell epitopes in whole gluten: chemical and immunological characterization.","volume":"312","author":"Marti","year":"2005","journal-title":"J Pharmacol Exp Ther."},{"key":"B41","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.1074129","article-title":"Structural basis for gluten intolerance in celiac sprue.","volume":"297","author":"Shan","year":"2002","journal-title":"Science."},{"key":"B42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/gut.2006.111609","article-title":"Efficient degradation of gluten by a prolyl endopeptidase in a gastrointestinal model: implications for celiac disease.","volume":"57","author":"Mitea","year":"2008","journal-title":"Gut."},{"key":"B43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/apt.13266","article-title":"Randomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers.","volume":"42","author":"Salden","year":"2015","journal-title":"Aliment Pharmacol Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.3748\/wjg.v19.i35.5837","article-title":"Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.","volume":"19","author":"Tack","year":"2013","journal-title":"World J Gastroenterol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/j.gastro.2007.05.028","article-title":"Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.","volume":"133","author":"Gass","year":"2007","journal-title":"Gastroenterology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1021\/jacs.5b08325","article-title":"Engineering of Kuma030: a gliadin peptidase that rapidly degrades immunogenic gliadin peptides in gastric conditions.","volume":"137","author":"Wolf","year":"2015","journal-title":"J Am Chem Soc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.","volume":"146","author":"L\u00e4hdeaho","year":"2014","journal-title":"Gastroenterology."},{"key":"B48","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/protein\/gzn050","article-title":"Protein engineering of improved prolyl endopeptidases for celiac sprue therapy.","volume":"21","author":"Ehren","year":"2008","journal-title":"Protein Eng Des Sel."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/nu10121927","article-title":"Gluten immunogenic peptides as standard for the evaluation of potential harmful prolamin content in food and human specimen.","volume":"10","author":"Cebolla","year":"2018","journal-title":"Nutrients."},{"key":"B50","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.3748\/wjg.v27.i37.6306","article-title":"Determination of gluten immunogenic peptides for the management of the treatment adherence of celiac disease: a systematic review.","volume":"27","author":"Coto","year":"2021","journal-title":"World J Gastroenterol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/apt.16075","article-title":"Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten-free diet.","volume":"52","author":"Silvester","year":"2020","journal-title":"Aliment Pharmacol Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/apt.13988","article-title":"Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet.","volume":"45","author":"Mahadev","year":"2017","journal-title":"Aliment Pharmacol Ther."},{"key":"B53","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1651-2227.2000.tb00408.x","article-title":"Gastric emptying of solids is delayed in celiac disease and normalizes after gluten withdrawal.","volume":"89","author":"Perri","year":"2020","journal-title":"Acta Pediatr."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.00029","article-title":"Recent progress and recommendations on celiac disease from the working group on prolamin analysis and toxicity.","volume":"7","author":"Scherf","year":"2020","journal-title":"Front Nutr."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.974771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T10:16:58Z","timestamp":1662632218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.974771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":54,"alternative-id":["10.3389\/fnut.2022.974771"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.974771","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"974771"}}